
Novavax: CIC And Flu Vaccine Candidates Induce Immune Responses Similar To Licensed Comparators
Novavax, Inc. (NVAX) reported results of the initial cohort of COVID-19-Influenza Combination and stand-alone trivalent hemagglutinin nanoparticle seasonal influenza Phase 3 trial that showed both the COVID-19-Influenza Combination and flu vaccine …